Moxetumomab pasudotox and Reteplase, recombinant Intravenous
Determining the interaction of Moxetumomab pasudotox and Reteplase, recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: reteplase
Brand name: Retavase, Retavase Half-Kit
Synonyms: Reteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Retin A
- Moxetumomab pasudotox-Retin-A (Tretinoin Cream)
- Moxetumomab pasudotox-Retin-A (Tretinoin Gel)
- Moxetumomab pasudotox-Retin-A Cream, Gel, Liquid
- Moxetumomab pasudotox-Retin-A Micro
- Moxetumomab pasudotox-Retin-A Micro Topical
- Reteplase, recombinant Intravenous-Moxetumomab Pasudotox-tdfk
- Reteplase, recombinant Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Reteplase, recombinant Intravenous-Moxifloxacin
- Reteplase, recombinant Intravenous-Moxifloxacin (Systemic)
- Reteplase, recombinant Intravenous-Moxifloxacin Hydrochloride
- Reteplase, recombinant Intravenous-Moxifloxacin Injection